Our investigational AortaFit™ System is designed to offer an easy to use, less invasive, personalized solution for the treatment of AAA. This proprietary system is comprised of three technology platforms: AortaFit Software, Precise Fenestration Application (PFA) Process and a Branch Fenestration Stent. The system is designed to precisely match endografts to each patient’s unique anatomy, thus allowing physicians to treat the over 40% of AAA patients who could benefit from EVAR. These patients currently either go to open surgery, which is often associated with higher risks and longer recovery times, or undergo standard EVAR, which is frequently associated with suboptimal results in this setting. Both these groups could benefit from the technology. This process is intended to improve graft anchoring, and minimize the potential of both endoleaks and graft migration.